New results from the NURTURE study have demonstrated that pre-symptomatic infants treated with Spinraza® achieved motor milestones not seen before.
Browsing: Development and pediatrics
A recent study has determined a connection between reduced redundant synapses of autism spectrum disorder mouse brains and exercise. This could offer a possibility of reversing behavioral defects seen in autism spectrum disorder.
For the first time, researchers have revealed that autism could result from mutations in the noncoding regions of the human genome.
In this interview, we spoke with Alysson Muotri about defining cell maturity in brain organoids and how we could address the challenges with these systems.
Neonatologists have determined that there may be links between disruption of placental allopregnanolone delivery to the fetus and brain injuries associated with autism.
Researchers have demonstrated that cerebral organoids grown at the air–liquid interface are able to generate nerve tracts and stimulate muscle output; these could be used to improve understanding of neurological diseases such as dementia.
A recent study has indicated that vitamin D affects perineuronal nets within the brain, which could facilitate the loss of brain plasticity.
This week we look at gammaCore™ for cluster headache, warnings of stroke risk with a multiple sclerosis drug and a gene therapy for spinal muscular atrophy.
The EMA has approved Gilenya® (fingolimod) for the treatment of children and adolescents with relapsing–remitting forms of multiple sclerosis.
A team of researchers have devised a novel method of diagnosing autism in children. Following analysis of short home videos of children, mathematical modelling was utilized to provide a numerical score indicating the severity of the developmental disorder.